Related references
Note: Only part of the references are listed.Geographic analysis of RKIP expression and its clinical relevance in colorectal cancer
V. H. Koelzer et al.
BRITISH JOURNAL OF CANCER (2013)
Raf kinase inhibitor protein expression combined with peritoneal involvement and lymphovascular invasion predicts prognosis in Dukes' B colorectal cancer patients
Brendan Doyle et al.
HISTOPATHOLOGY (2013)
RKIP: Much more than Raf Kinase inhibitory protein
Fahd Al-Mulla et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
IL-6/IL-6 receptor system and its role in physiological and pathological conditions
Masahiko Mihara et al.
CLINICAL SCIENCE (2012)
A New Model for Raf Kinase Inhibitory Protein Induced Chemotherapeutic Resistance
Fahd Al-Mulla et al.
PLOS ONE (2012)
Regulation of RKIP Function by Helicobacter pylori in Gastric Cancer
Erika L. Moen et al.
PLOS ONE (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
The DNA damage mark pH2AX differentiates the cytotoxic effects of small molecule HDAC inhibitors in ovarian cancer cells
Andrew J. Wilson et al.
CANCER BIOLOGY & THERAPY (2011)
STAT3 Is Necessary for Proliferation and Survival in Colon Cancer-Initiating Cells
Li Lin et al.
CANCER RESEARCH (2011)
Systematic analysis of proteins from different signaling pathways in the tumor center and the invasive front of colorectal cancer
Eva Karamitopoulou et al.
HUMAN PATHOLOGY (2011)
Dynamics of the STAT3 Transcription Factor: Nuclear Import Dependent on Ran and Importin-β1
Velasco Cimica et al.
PLOS ONE (2011)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer
Eva Karamitopoulou et al.
HISTOPATHOLOGY (2010)
Immunogenic death of colon cancer cells treated with oxaliplatin
A. Tesniere et al.
ONCOGENE (2010)
Interleukin-6 in the Bone Marrow Microenvironment Promotes the Growth and Survival of Neuroblastoma Cells
Tasnim Ara et al.
CANCER RESEARCH (2009)
Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3
Eric Van Cutsem et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
Thierry Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Inverse association between Raf Kinase Inhibitory Protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: Implications for clinical outcome
Devasis Chatterjee et al.
CLINICAL CANCER RESEARCH (2008)
Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy
Doris Germain et al.
CLINICAL CANCER RESEARCH (2007)
The resurgence of platinum-based cancer chemotherapy
Lloyd Kelland
NATURE REVIEWS CANCER (2007)
Loss of Raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer
Parham Minoo et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan
Maguy Del Rio et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients
Fahd Al-Mulla et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Interleukin-6 level in patients with colorectal cancer
Farideh Esfandi et al.
CANCER LETTERS (2006)
Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation
MB Resnick et al.
HUMAN PATHOLOGY (2005)
Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer
R Atreya et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2005)
Expression of activated signal transducer and activator of transcription 3 predicts expression of vascular endothelial growth factor in and angiogenic phenotype of human gastric cancer
WD Gong et al.
CLINICAL CANCER RESEARCH (2005)
Stat3 dimerization regulated by reversible acetylation of a single lysine residue
ZL Yuan et al.
SCIENCE (2005)
RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis
D Chatterjee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Colon cancer survival rates with the new American Joint Committee on cancer sixth edition staging
JB O'Connell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling
C Becker et al.
IMMUNITY (2004)
Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy
SL Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein
KC Corbit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism
GJ Peters et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2002)
The crystal structure of PEBP-2, a homologue of the PEBP/RKIP family
PC Simister et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2002)
Paracrine repercussions of preconditioning on angiogenesis and apoptosis of endothelial cells
MA Raymond et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Raf kinase inhibitor protein interacts with NF-κB-inducing kinase and TAK1 and inhibits NF-κ13 activation
KC Yeung et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells
R Garcia et al.
ONCOGENE (2001)
Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells
B Gao et al.
FEBS LETTERS (2001)
Negative regulation of Janus kinases
RJ Duhe et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2001)
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
A de Gramont et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial
JY Douillard et al.
LANCET (2000)
Share Paper
